BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38303345)

  • 21. Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.
    Xin Y; Cao F; Yang H; Zhang X; Chen Y; Cao X; Zhou X; Li X; Zhou J
    Front Immunol; 2022; 13():929141. PubMed ID: 35990634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage Surgery for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Downstaged by Hepatic Arterial Infusion Chemotherapy.
    Goto Y; Hisaka T; Sakai H; Takagi K; Fukutomi S; Akagi Y; Okuda K
    Anticancer Res; 2020 Aug; 40(8):4773-4777. PubMed ID: 32727804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
    Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW
    Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma.
    Zhou H; Song T
    Biosci Trends; 2021 Jul; 15(3):155-160. PubMed ID: 34039818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
    Song MJ
    World J Gastroenterol; 2015 Apr; 21(13):3843-9. PubMed ID: 25852268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination Therapy of Hepatic Arterial Infusion Chemotherapy and Surgical Resection against Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis].
    Kimura Y; Tokumitsu Y; Matsukuma S; Matsui H; Shindo Y; Nakajima M; Yoshida S; Iida M; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Hazama S; Ueno T; Nagano H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):760-762. PubMed ID: 31164527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Adding Locoregional Therapy in Non-Complete Remission Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Preliminary Study.
    Ishikawa T; Yamazaki S; Sato R; Jimbo R; Kobayashi Y; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
    Anticancer Res; 2024 Jan; 44(1):361-368. PubMed ID: 38159993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.
    Shao YY; Huang CC; Liang PC; Lin ZZ
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):80-8. PubMed ID: 20565419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
    Yoshimoto T; Imura S; Morine Y; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Takasu C; Ishikawa D; Teraoku H; Bando Y; Shimada M
    Anticancer Res; 2018 Jan; 38(1):501-507. PubMed ID: 29277815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
    Wada H; Nagano H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Sakon M; Wakasa K; Monden M
    J Gastroenterol; 2007 Jun; 42(6):501-6. PubMed ID: 17671767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The progresses of liver resection for solitary large hepatocellular carcinoma].
    Yang LY
    Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):13-16. PubMed ID: 31902163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
    Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
    J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Hatano E; Uemoto S; Yamaue H; Yamamoto M;
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):395-402. PubMed ID: 30091239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Patient Outcome after Non-curative Resection for Hepatocellular Carcinoma Using Nationwide Survey Data in Japan.
    Aoki T; Kubota K; Kubo S; Eguchi S; Izumi N; Kokudo N; Sakamoto M; Shiina S; Takayama T; Nakashima O; Matsuyama Y; Murakami T; Kudo M
    World J Surg; 2021 Feb; 45(2):607-614. PubMed ID: 33104834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
    DʼAngelica MI; Correa-Gallego C; Paty PB; Cercek A; Gewirtz AN; Chou JF; Capanu M; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N
    Ann Surg; 2015 Feb; 261(2):353-60. PubMed ID: 24646562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection of hepatocellular carcinoma with tumor thrombus of the portal vein after neoadjuvant regional chemotherapy.
    Kamiyama H; Toyama N; Mori Y; Miyazaki K; Nagano M; Yamada S; Suminaga Y; Konishi F
    J Hepatobiliary Pancreat Surg; 2002; 9(6):759-63. PubMed ID: 12658413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis.
    Hu L; Zheng Y; Lin J; Shi X; Wang A
    World J Surg Oncol; 2023 Apr; 21(1):121. PubMed ID: 37013589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two cases of hepatocellular carcinoma successfully treated by carbon ion radiotherapy after atezolizumab plus bevacizumab treatment.
    Takakusagi S; Tanaka H; Naganuma A; Kakizaki S; Shibuya K; Ohno T; Takagi H; Uraoka T
    Clin J Gastroenterol; 2023 Jun; 16(3):407-415. PubMed ID: 36750524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for Hepatocellular Carcinoma With Macroscopic Vascular Invasion in the Era of Modern Molecular Therapy.
    Yamamura K; Beppu T; Miyata T; Mima K; Okabe H; Nitta H; Imai K; Hayashi H; Oda E; Karashima R; Ozaki N; Isiko T
    Anticancer Res; 2023 Oct; 43(10):4285-4293. PubMed ID: 37772548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.